Financial Enhancement Group LLC Merck & Co., Inc. Transaction History
Financial Enhancement Group LLC
- $545 Million
- Q1 2024
A detailed history of Financial Enhancement Group LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Financial Enhancement Group LLC holds 44,265 shares of MRK stock, worth $5.65 Million. This represents 1.07% of its overall portfolio holdings.
Number of Shares
44,265
Previous 44,470
0.46%
Holding current value
$5.65 Million
Previous $4.85 Million
20.46%
% of portfolio
1.07%
Previous 0.91%
Shares
15 transactions
Others Institutions Holding MRK
# of Institutions
3,767Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$31.1 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26.4 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$15 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$11 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.2 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $324B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...